Literature DB >> 1680492

Ectopic expression of mucins in colorectal cancer metastasis.

T Irimura1, Y Matsushita, S D Hoff, T Yamori, S Nakamori, M L Frazier, G G Giacco, K R Cleary, D M Ota.   

Abstract

Cancer metastasis is an ectopic growth of malignant cells. In human colorectal cancer, it is hypothesized that, during the progression of the disease to an advanced stage, highly malignant and metastatic tumor cells arise within primary tumors and become predominant. Based on this hypothesis, molecules associated with metastatic cells have been sought by the comparison of surgical specimens from patients at various clinical stages. Colorectal carcinomas with increased metastatic potential and with poor prognosis have been characterized by a loss of an organ-specific mucin determinant (sulfomucin), by an increased expression of non-intestinal sialomucins, and by an ectopic expression of adhesion ligands (sialyl-dimeric Lex antigens) on mucins.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1680492

Source DB:  PubMed          Journal:  Semin Cancer Biol        ISSN: 1044-579X            Impact factor:   15.707


  9 in total

1.  Mucus glycoproteins, super glycoforms: how to solve a sticky problem?

Authors:  T Corfield
Journal:  Glycoconj J       Date:  1992-10       Impact factor: 2.916

2.  Selectin ligands on human melanoma cells.

Authors:  N Miller; R G Vile; I R Hart
Journal:  Glycoconj J       Date:  1996-02       Impact factor: 2.916

3.  Malignant and other properties of human colon carcinoma cells after suppression of sulfomucin production in vitro.

Authors:  H Tsuiji; S Nakatsugawa; T Ishigaki; T Irimura
Journal:  Clin Exp Metastasis       Date:  1999-03       Impact factor: 5.150

4.  Expression of MUC1 recognized by a monoclonal antibody MY.1E12 is a useful biomarker for tumor aggressiveness of carcinoma of the gallbladder.

Authors:  Toru Kawamoto; Junichi Shoda; Naoki Miyahara; Hideo Suzuki; Masato Furukawa; Takeshi Todoroki; Naomi Tanaka; Tatsuro Irimura
Journal:  Clin Exp Metastasis       Date:  2004       Impact factor: 5.150

5.  Expression of MUC1 recognized by monoclonal antibody MY.1E12 is a useful biomarker for tumor aggressiveness of advanced colon carcinoma.

Authors:  Hideo Suzuki; Junichi Shoda; Toru Kawamoto; Eiji Shinozaki; Naoki Miyahara; Souichi Hotta; Yasushi Iizuka; Akira Nakahara; Naomi Tanaka; Akinori Yanaka; Tatsuro Irimura
Journal:  Clin Exp Metastasis       Date:  2004       Impact factor: 5.150

6.  N-Acetylgalactosaminyltransferase-14 as a potential biomarker for breast cancer by immunohistochemistry.

Authors:  Chen Wu; Xiaodan Guo; Weina Wang; Yun Wang; Yaojun Shan; Bo Zhang; Wenqian Song; Sisi Ma; Jianfeng Ge; Hao Deng; Mingsheng Zhu
Journal:  BMC Cancer       Date:  2010-04-01       Impact factor: 4.430

7.  Invasive behavior of ulcerative colitis-associated carcinoma is related to reduced expression of CD44 extracellular domain: comparison with sporadic colon carcinoma.

Authors:  Tetuo Mikami; Tsutomu Yoshida; Yoshiko Numata; Masaomi Kikuchi; Kayo Araki; Norihiro Nakada; Isao Okayasu
Journal:  Diagn Pathol       Date:  2011-04-07       Impact factor: 2.644

8.  Expression of MUC1 mucins inversely correlated with post-surgical survival of renal cell carcinoma patients.

Authors:  K Fujita; K Denda; M Yamamoto; T Matsumoto; M Fujime; T Irimura
Journal:  Br J Cancer       Date:  1999-04       Impact factor: 7.640

9.  Expression of mucin-associated sulfo-Lea carbohydrate epitopes on human colon carcinoma cells.

Authors:  H Tsuiji; M Hayashi; D M Wynn; T Irimura
Journal:  Jpn J Cancer Res       Date:  1998-12
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.